Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) Net Margin (2023 - 2025)

Onconetix (ONCO) has disclosed Net Margin for 2 consecutive years, with 11936.73% as the latest value for Q4 2024.

  • On a quarterly basis, Net Margin rose 8151.0% to 11936.73% in Q4 2024 year-over-year; TTM through Dec 2024 was 3766.32%, a 1017203.0% decrease, with the full-year FY2024 number at 6743.21%, up 7072969.0% from a year prior.
  • Net Margin was 11936.73% for Q4 2024 at Onconetix, up from 940.72% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 11936.73% in Q4 2024 to a low of 176262.79% in Q1 2023.